Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity | Zendy

C Briguori | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity

Author(s) -

C Briguori

Publication year - 2004

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1016/j.ehj.2003.11.016

Subject(s) - medicine , nephrotoxicity , creatinine , renal function , urology , saline , acetylcysteine , contrast (vision) , nephropathy , toxicity , anesthesia , endocrinology , antioxidant , biochemistry , chemistry , artificial intelligence , diabetes mellitus , computer science

Prophylactic administration of N-acetylcysteine (NAC) (600mg orally twice daily), along with hydration, prevents contrast agent-associated nephrotoxicity (CAN) induced by a low dose of non-ionic, low-osmolality contrast dye. We tested whether a double dose of NAC is more effective to prevent CAN.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research